Eltrombopag reduces clinically relevant thrombocytopenic events in higher risk MDS and AML

Research output: Contribution to journalComment/debatepeer-review

4 Scopus citations

Fingerprint Dive into the research topics of 'Eltrombopag reduces clinically relevant thrombocytopenic events in higher risk MDS and AML'. Together they form a unique fingerprint.